Immunolocalization of annexins IV, V and VI in the failing and non- failing human heart

Cardiovascular Research

Volumn 45, Issue 4, 2000, Pages 961-970

  Matteo, Rosalia G ^a   Moravec, Christine Schomisch ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Ca pump; Calcium (cellular); Cardiomyopathy; Heart failure; Sarcolemma

Indexed keywords

CALPHOBINDIN II; LIPOCORTIN 4; LIPOCORTIN 5;

ADULT; AGED; ARTICLE; CALCIUM TRANSPORT; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HUMAN; HUMAN TISSUE; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SARCOLEMMA;

ADOLESCENT; ADULT; AGED; ANNEXIN A4; ANNEXIN A5; ANNEXIN A6; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CASE-CONTROL STUDIES; CYTOPLASM; FEMALE; HEART ATRIA; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MYOCARDIUM; SARCOLEMMA; STATISTICS, NONPARAMETRIC;

EID: 0033951316     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00409-5     Document Type: Article

References (45)

1. i handling in human ventricular myocytes from patients with terminal heart failure. Am Heart J. 129:1995;684-689.
2. 2+ release activity of sarcoplasmic reticulum in dilated cardiomyopathy. Circulation. 85:1992;518-525.
3. 2+ transients in failing human myocardium assessed with ryanodine. J Mol Cell Cardiol. 30:1998;1285-1294.
4. Brillantes A.M., Allen P., Takahashi T., Izumo S., Marks A.R. Differences in cardiac calcium release channel (rayanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy. Circ Res. 71:1992;18-26.
5. 2+ exchanger in failing human myocardium. Circulation. 94:1996;992-1002.
6. Feldman A.M., Phillip E.R., Silan C.M., Mercer J.A., Minobe W., Bristow M.R. Quantification of steady-state levels of messenger RNA in endotmyocardial biopsies using the polymerase chain reaction. Circulation. 83:1991;1866-1872.
7. 2+-transporting ATPase phospholamban, and calsequestrin levels in non-failing and failing human myocardium. Circulation. 90:1994;653-657.
8. Movsesian M.A. Calcium uptake by sarcoplasmic reticulum and its modulation by cAMP-dependent phosphorylation in normal and failing human myocardium. Basic Res Cardiol. 87:1992;277-284.
9. Bohm M., Reiger B., Schwinger R.H.G., Erdmann E. cAMP concentrations, cAMP dependent protein kinase activity, and phospholamban in non-failing and failing myocardium. Cardiovasc Res. 28:1994;1713-1719.
10. + currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res. 73:1993;379-385.
11. Ouadid H., Albat B., Nargeot J. Calcium currents in diseased human cardiac cells. J Cardiovasc Pharmacol. 25:1995;282-291.
12. Raynal P., Pollard H.B. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta. 1197:1994;63-93.
13. Swairjo M.A., Seaton B.A. Annexin structure and membrane interactions: a molecular perspective. Annu Rev Biophys Biomol Struct. 23:1994;193-213.
14. Kaetzel M.A., Chan H.C., Dubinsky W.P., Dedman J.R., Nelson D.J. A role for annexin IV in epithelial cell function. Inhibition of calcium-activated chloride conductance. Biochem Mol Biol. 269:1994;5297-5302.
15. Rojas E., Pollard H.B., Haigler H.T., Parra C., Burns A.L. Calcium-activated endonexin II forms calcium channels across acidic phospholipid membranes. J Biol Chem. 265:1990;21207-21215.
16. Berendes R., Burger A., Voges D., Demange P., Huber R. Calcium influx through annexin V ion channels into large unilamellar vesicles measured with fura-2. FEBS Lett. 317:1993;131-134.
17. 2+-release channel requires intact annexin VI. J Cell Biochem. 46:1991;86-93.
18. 2+ exchange activity. Biochem Biophys Res Commun. 172:1990;1067-1072.
19. Gunteski-Hamblin A., Song G., Walsh R.A., et al. Annexin VI overexpression targeted to heart alters cardiomyocyte function in transgenic mice. Am J Physiol. 270:1996;H1091-H1100.
20. Doubell A.F., Bester A.J., Thibault G. Annexin V and VI: major calcium-dependent atrial secretory granule-binding proteins. Hypertension. 18:1991;648-656.
21. Schlaepfer D., Jones J., Haigler H.T. Inhibition of protein kinase C by annexin V. Biochemistry. 31:1992;1886-1891.
22. Rothhut B., Dibois T., Feliers D., Russo-Marie F., Oudinet J.P. Inhibitory effect of annexin V on protein kinase C activity in mesanglial cell lysates. Eur J Biochem. 31:1995;1886-1891.
23. 2+ release channel activity from sarcoplasmic reticulum by annexin VI (67-kDa Calcimedin). J Biol Chem. 265:1990;15894-15899.
24. Jeck C.D., Zimmermann R., Schaper J., Schaper W. Decreased expression of calmodulin mRNA in human end-stage heart failure. J Mol Cell Cardiol. 26:1994;99-107.
25. van Bilsen M., Reutelingsperger C.P.M., Willemsen P.H.M., Reneman R.S., van der Vusse G.J. Annexins in cardiac tissue: cellular localization and effect on phospholipase activity. Mol Cell Biochem. 116:1992;95-101.
26. Doubell A.F., Lazure C., Charbonneau C., Thibault G. Identification and immunolocalization of annexins V and VI, the major cardiac annexins, in the rat heart. Cardiovasc Res. 27:1993;1359-1367.
27. Jans S.W.S., van Bilsen M., Reutelingsperger C.M.P., Borgers M., de Jong Y.F., van der Vusse G.J. Annexin V in the adult rat heart: isolation, localization and quantification. J Mol Cell Cardiol. 27:1995;335-348.
28. Wang L., Rahman M., Iida H., et al. Annexin V is localized in association with Z-line of rat cardiac myocytes. Cardiovasc Res. 30:1995;363-371.
29. Song G., Campos B., Wagoner L.E., Dedman J.R., Walsh R. Altered cardiac annexin mRNA and protein levels in the left ventricle of patients with end-stage heart failure. J Mol Cell Cardiol. 30:1998;443-451.
30. Keneko N., Matsuda R., Chiwaki F., Hosoda S. Purification of cardiac annexin V from the beagle dog heart and changes in its localization in the ischemic rat heart. Heart Vessels. 9:1994;148-154.
31. Romisch J., Schuler E., Bastian B., et al. Annexins I to VI: quantitative determination in different human cell types and in plasma after myocardial infarction. Blood Coagul Fibrinolysis. 3:1992;11-17.
32. Moravec C.S., Schluchter M.D., Paranandi L., et al. Inotropic effects of angiotensin II on human cardiac muscle in vitro. Circulation. 82:1990;1973-1984.
33. Bradford M.M. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Ann Biochem. 72:1978;248-254.
34. 4. Nature. 227:1970;680-685.
35. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 76:1979;4350-4354.
36. Gwathmey J.K., Copelas L., MacKinnon R., et al. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res. 61:1987;70-76.
37. Wankerl M., Schwartz K. Calcium transport proteins in non-failing and failing heart: gene expression and function. J Mol Med. 73:1995;487-496.
38. Schaper J., Froede R., Hem S., et al. Impairment of myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation. 83:1998;504-514.
39. Hein S., Scholz D., Fujitani N., et al. Altered expression of titin and contractile proteins in failing human myocardium. J Mol Cell Cardiol. 26:1994;1291-1306.
40. Massey D., Traverso V., Rigal A., Moroux S. Cellular and subcellular localization of annexin IV in rabbit intestinal epithelium, pancreas and liver. Biol Cell. 73:1991;151-156.
41. Kojima K., Yamamoto K., Irimura T., Osawa T., Ogawa H., Matsumoto I. Characterization of carbohydrate-binding protein p33/41. Relation with annexin IV, molecular basis of doublet forms (p33 and p41), and modulation of the carbohydrate binding activity by phospholipids. J Biol Chem. 271:1996;7679-7685.
42. Gianbanco I., Pula G., Ceccarelli P., Bianchi R., Donato R. Immunohistochemical localization of annexin V(CaBP33) in rat organs. J Histochem Cytochem. 39:1991;1189-1198.
43. Trouvé P., Legot S., Bélikova I., et al. Localization and quantification of cardiac annexins II, V, and VI in hypertensive guinea pigs. Am J Physiol. 276:1999;1159-1166.
44. 2+-dependent phospholipid and membrane-binding protein, in the rat nervous system and skeletal muscle and in the porcine heart. J Cell Physiol. 152:1992;587-598.
45. 2+ exchanger in end-stage human heart failure. Circ Res. 75:1994;443-453.